Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry.

Zayd A Eldadah,Amin Al-Ahmad,T Jared Bunch,David B Delurgio,Rahul N Doshi,Bruce G Hook,Patrick M Hranitzky, Charles A Joyner,Suneet Mittal, Christopher Porterfield,Javier E Sanchez,Senthil K Thambidorai,Oussama M Wazni,H Thomas McElderry

Journal of Cardiovascular Electrophysiology（2023）

引用 1|浏览2

暂无评分

摘要

In this study, 99.7% of patients achieving SDD required no additional hospital intervention for access site-related complications during follow-up. SDD appears feasible and safe for eligible patients after catheter ablation for paroxysmal or persistent AF in which the VASCADE MVP is used for venous access-site closure.

查看译文

关键词

VASCADE MVP,atrial fibrillation,catheter ablation,patient-reported outcomes,same-day discharge

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要